November 1, 2004American Journal of Hypertension
Insights into the biology of diabetic vascular disease: What?s new?
Key result
Cardiovascular prevention strategies including RAAS blockers reduce cardiovascular and renal risk in diabetes.
Why the study?
Cardiovascular disease is the major cause of morbidity and mortality in persons with diabetes, with complex pathophysiology involving hypertension, insulin resistance, and RAAS-mediated dysfunction, necessitating updated insights into prevention strategies.
Population
Persons with diabetes at risk for cardiovascular disease
Comparison
Cardiovascular disease prevention strategies including aspirin, lipid-lowering agents, antihypertensive agents, and RAAS blocking agents
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports multifactorial prevention including RAAS blockade in diabetes; leaves open questions on optimal integration of newer agents.
Structured PICO
P
Population
Persons with diabetes
I
Intervention
Cardiovascular disease prevention strategies including aspirin, lipid-lowering agents, antihypertensive agents, and RAAS blocking agents
O
Outcome
Cardiovascular events
This review highlights the pathophysiology of diabetic vascular disease, emphasizing the role of the RAAS and the importance of multifactorial risk reduction including BP control and RAAS blockade.
Cite This Study
Sowers et al. (2004) conducted a review in Diabetes and cardiovascular disease. Cardiovascular disease prevention strategies in diabetes, including blood pressure control and RAAS blocking agents, reduce cardiovascular and renal risk.